Exchange: NASDAQ·Updated 04:00 PM EDT
NUVL logo

NUVLNuvalent Inc - Ordinary Shares - Class A

$123.96
$0.02
(0.02%)
Today
EarningsAug 6
Mkt Cap$9.79B
Vol3.09M

About

Nuvalent is a biopharmaceutical company that develops targeted therapies for cancer by designing small-molecule medicines that address treatment resistance and improve selectivity against validated kinase targets. The company applies structure-based drug design and collaborates with clinical researchers to create therapies for patients whose cancers are driven by specific genetic alterations. Its pipeline includes investigational treatments for ROS1-positive, ALK-positive, and HER2-altered cancers, with programs spanning multiple stages of clinical development. Nuvalent also conducts clinical trials and research activities focused on expanding treatment options for patients with solid tumors and other oncology indications.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
228

Frequently Asked Questions

What is Market Cap of Nuvalent Inc - Ordinary Shares - Class A?
What is the 52-week high for Nuvalent Inc - Ordinary Shares - Class A?
What is the 52-week low for Nuvalent Inc - Ordinary Shares - Class A?
What is Nuvalent Inc - Ordinary Shares - Class A stock price today?
What was Nuvalent Inc - Ordinary Shares - Class A stock price yesterday?
What is the PE ratio of Nuvalent Inc - Ordinary Shares - Class A?
What is the Price-to-Book ratio of Nuvalent Inc - Ordinary Shares - Class A?
What is the 50-day moving average of Nuvalent Inc - Ordinary Shares - Class A?
How many employees does Nuvalent Inc - Ordinary Shares - Class A have?

Advertisement|Remove ads.